Making medicines evergreen

Affiliations

Review

Andrew W Hitchings et al. BMJ. 2012.

. 2012 Nov 29:345:e7941.

doi: 10.1136/bmj.e7941.

¹ Division of Biomedical Sciences, St George's, University of London, London SW17 0RE, UK. ahitchin@sgul.ac.uk

No abstract available

Comment in

Another loophole exploited by the drug industry.
Brunet MD. Brunet MD. BMJ. 2013 Jan 22;346:f354. doi: 10.1136/bmj.f354. BMJ. 2013. PMID: 23341559 No abstract available.
Flynn Pharma's reply to Brunet.
Walters D. Walters D. BMJ. 2013 Jan 22;346:f358. doi: 10.1136/bmj.f358. BMJ. 2013. PMID: 23341560 No abstract available.
Developing a new drug costs less than $100m, not $900m.
Gøtzsche PC. Gøtzsche PC. BMJ. 2013 Jan 22;346:f398. doi: 10.1136/bmj.f398. BMJ. 2013. PMID: 23341561 No abstract available.